ID
20839
Description
Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00306384
Link
https://clinicaltrials.gov/show/NCT00306384
Keywords
Versions (1)
- 3/21/17 3/21/17 -
Uploaded on
March 21, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Diabetes Mellitus NCT00306384
Eligibility Diabetes Mellitus NCT00306384
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Adverse event
Data type
boolean
Alias
- UMLS CUI [1]
- C0877248
Description
Pharmacotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0013216
Description
Weight-loss drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0376606
Description
Investigational antidiabetics
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0935929
- UMLS CUI [1,2]
- C0304229
Description
Incretin mimetics
Data type
boolean
Alias
- UMLS CUI [1]
- C3839883
Description
Glucocorticoids
Data type
boolean
Alias
- UMLS CUI [1]
- C0017710
Similar models
Eligibility Diabetes Mellitus NCT00306384
- StudyEvent: Eligibility
C0006147 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C2348568 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
C0304229 (UMLS CUI [1,2])